Mifepristone Tablet, Film Coated
Product Images NDC 0591-4390

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mifepristone (NDC 0591-4390). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure of Mifepristone, a corticosteroid derivative used as a prescription drug. The diagram shows the labeled carbon rings and functional groups characteristic of the molecule.*

FDA Label Image

1 (Image 2)

Mifepristone Tablets 300 mg oral film-coated tablets in a strip pack with 28 tablets, labeled by Actavis Pharma, Inc. The label includes the NDC number 0591-4390, instructions to take tablets whole without splitting, crushing, or chewing, and a pharmacist advisory to dispense the medication guide to each patient. The Teva logo appears in green on the bottom right.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.